期刊文献+

冠状动脉无复流的研究进展

原文传递
导出
摘要 急诊经皮冠状动脉介入治疗(PCI)是治疗急性心肌梗死(AMI)的重要方法,但有部分患者梗死血管开通后心肌灌注不良,此种现象即为无复流。无复流可能的发生机制包括:血管内皮损伤、微栓塞、白细胞聚集、氧自由基的激活、血小板及凝血级联反应的激活等。研究提示,一些临床因素和生化指标的异常与无复流的发生密切相关,而应用血管扩张剂、抗血小板药物、血栓抽吸装置、远端保护装置、缺血预适应等可预防无复流。无复流的发生提示预后不良,进而越来越引起人们的重视。现就无复流的研究进展综述如下。
出处 《中国实用医刊》 2012年第10期97-99,共3页 Chinese Journal of Practical Medicine
  • 相关文献

参考文献18

  • 1Galuto L. Optimal therapeutic strategies in the setting of post-infarction no reflow:the need for a pathogenetic classification[J].Heart,2004,(02):123-125.doi:10.1136/hrt.2003.020800.
  • 2Topoi EJ,Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease[J].Circulation,2000,(05):570-580.
  • 3Kleinbongard P,Bose D,Baars T. Vasoconstrictor potential of coronary aspirate from patients undergoing stenting of saphenous vein aortocoronary bypass grafts and its pharmacological attenuation[J].Circulation Research,2011,(03):344-352.doi:10.1161/CIRCRESAHA.110.235713.
  • 4Golino P,Ragni M,Cirillo P. Recombinant human active siteblocked factor Ⅶ reduces infract size and no-reflow phenomenon in rabbits[J].Am J Physinl,2000,(05):1507-1516.
  • 5Kupatt C,Wichels R,Horstkotte J. Molecular mechanisms of platelet mediated leukocyte recruitment during myocardial reperfusion[J].Journal of Leukocyte Biology,2002,(03):455-461.doi:10.1142/S0218196711006856.
  • 6Yip HK,Chen MC,Chang HW. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction:predictors of slow-flow and no-reflow phenomenon[J].Chest,2002,(04):1322-1332.
  • 7Oduncu V,Tanalp AC,Erkol A. Impact of chronic pre-treatment of statins on the level of systemic inflammation and myocardial peffusion in patients undergoing primary angioplasty[J].Journal of the American College of Cardiology,2011,(02):179-185.
  • 8Takahashi T,Hissa Y,Dhara Y. Relation between neutrophil counts on admission,microvascular injury,and left ventricular functional recovery in patients with an anterior wall first acute myocardial infaction treated with primary coronary angioplasty[J].American Journal of Cardiology,2007,(01):35-40.doi:10.1016/j.amjcard.2007.02.049.
  • 9Niccoli G,Lanza GA,Shaw S. Endothelin-1 and acute myocardial infarction:a no-reflow mediator after successful percutaneous myocardial revascularization[J].European Heart Journal,2006,(05):1793-1798.
  • 10Henriques JP,Zijlstra F,Arnoud WJ. Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade[J].Circulation,2003,(16):2115-2119.doi:10.1161/01.CIR.0000065221.06430.ED.

二级参考文献8

  • 1赵京林,杨跃进,尤士杰,荆志成,吴永建,杨伟宪,陈纪林,高润林,陈在嘉.腺苷对猪急性心肌梗死再灌注后内皮素-1的影响[J].中国医学科学院学报,2006,28(2):225-229. 被引量:8
  • 2Pernow J, Wang Q D. Endothelin in ischaemia and reperfusion [J]. Cardiovasc Res, 1997, 33 (3) : 518-526.
  • 3Niccoli G, Lanza G A, Shaw S, et al. Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization [ J ]. Eur Heart J, 2006, 27 ( 15 ) : 1793-1798.
  • 4Katsuomi Iwakura, Ito H, Kawano S, et al. Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction [J]. Eur Heart J, 2006 , 27(5) :534-539.
  • 5Herrmann J. Peri-procedural myocardial injury: 2005 update [J]. Eur Heart J, 2005, 26(23) : 2493-2519.
  • 6Ito H. No-reflow phenomenon and prognosis in patients with acute myocardial infarction [J]. Nat Clin Pract Cardiovasc Med, 2006, 3 (9) : 499-506
  • 7Patti G, Pasceri V, Colonna G, et al. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial [J]. J Am Coll Cardiol, 2007, 49(12):1272-1278.
  • 8Lefer D J. Statins as potent antiinflammatory drugs [J]. Circulation, 2002, 106(16) : 2041-2042.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部